Mark James Litton Sells 25,107 Shares of Athira Pharma, Inc. (NASDAQ:ATHA) Stock
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) CEO Mark James Litton sold 25,107 shares of Athira Pharma stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $0.56, for a total value of $14,059.92. Following the sale, the chief executive officer now directly owns 242,591 shares of […]
More Stories
Lockheed Martin Co. (NYSE:LMT) Shares Acquired by Diversified Trust Co
Diversified Trust Co lifted its holdings in Lockheed Martin Co. (NYSE:LMT – Free Report) by 6.0% in the fourth quarter,...
Diversified Trust Co Buys 202 Shares of TransDigm Group Incorporated (NYSE:TDG)
Diversified Trust Co lifted its stake in shares of TransDigm Group Incorporated (NYSE:TDG – Free Report) by 5.3% in the...
Diversified Trust Co Acquires 1,192 Shares of AT&T Inc. (NYSE:T)
Diversified Trust Co boosted its stake in shares of AT&T Inc. (NYSE:T – Free Report) by 0.7% during the 4th...
Diversified Trust Co Purchases 1,700 Shares of iShares 0-3 Month Treasury Bond ETF (NYSEARCA:SGOV)
Diversified Trust Co increased its position in iShares 0-3 Month Treasury Bond ETF (NYSEARCA:SGOV – Free Report) by 3.0% in...
Moller Wealth Partners Acquires 7,707 Shares of Dimensional Core Fixed Income ETF (NYSEARCA:DFCF)
Moller Wealth Partners increased its stake in shares of Dimensional Core Fixed Income ETF (NYSEARCA:DFCF – Free Report) by 2.3%...
Moller Wealth Partners Increases Position in Vanguard FTSE All-World ex-US Small-Cap ETF (NYSEARCA:VSS)
Moller Wealth Partners grew its position in shares of Vanguard FTSE All-World ex-US Small-Cap ETF (NYSEARCA:VSS – Free Report) by...